Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: The pathogenic relevance to HLA class II alleles and disease severity

British Journal of Dermatology

Volumn 154, Issue 1, 2006, Pages 90-98

  Oyama, N ^a,b   Setterfield, J F ^c   Powell, A M ^a   Sakuma Oyama, Y ^a,b   Albert, S ^a   Bhogal, B S ^a   Vaughan, R W ^c   Kaneko, F ^b   Challacombe, S J ^c   Black, M M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Basement membrane zone antigens; Bullous pemphigoid; Cicatricial pemphigoid; Immunoglobulin isotype; Linear IgA bullous dermatosis

Indexed keywords

ANTIGEN; AUTOANTIGEN; BETA4 INTEGRIN; BULLOUS PEMPHIGOID 180 ANTIGEN; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KALININ; UNCLASSIFIED DRUG;

ADULT; AGED; AMNION; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ARTICLE; BASEMENT MEMBRANE; BULLOUS SKIN DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; EYE DISEASE; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PEMPHIGOID; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; AUTOANTIBODIES; AUTOANTIGENS; BASEMENT MEMBRANE; FEMALE; GENES, MHC CLASS II; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LAMININ; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 33644885761     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06998.x     Document Type: Article

References (45)

1. Chan LS Ahmed AR Anhalt GJ et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators Arch Dermatol 2002 138 370 9
2. Fleming TE Korman NJ Cicatricial pemphigoid J Am Acad Dermatol 2000 43 571 91
3. Zillikens D BP180 as the common autoantigen in blistering diseases with different clinical phenotypes Keio J Med 2002 51 21 8
4. Setterfield J Shirlaw PJ Kerr-Muir M et al. Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease Br J Dermatol 1998 138 602 10
5. Setterfield J Shirlaw PJ Bhogal BS et al. Cicatricial pemphigoid: serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity Br J Dermatol 1999 140 645 50
6. Murakami H Nishioka S Setterfield J et al. Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid J Dermatol Sci 1998 17 39 44
7. Domloge-Hultsch N Anhalt GJ Gammon WR et al. Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder Arch Dermatol 1994 130 1521 9
8. Tyagi S Bhol K Natarajan K et al. Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization Proc Natl Acad Sci USA 1996 93 14714 9
9. Wieme N Lambert J Moerman M et al. Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid Dermatology 1999 198 310 3
10. 4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230 Br J Dermatol 2001 145 998 1004
11. Egan CA Lazarova Z Darling TN et al. Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations Medicine (Baltimore) 2003 82 177 86
12. Tilkin AF Vinci G Michon J Levy JP Autoreactive HLA-DR-specific autoreactive T-cell clones: possible regulatory function for B lymphocytes and hematopoietic precursors Immunol Rev 1990 116 171 81
13. Venning VA Taylor CJ Ting A Wojnarowska F HLA type in bullous pemphigoid, cicatricial pemphigoid and linear IgA disease Clin Exp Dermatol 1989 14 283 5
14. Yunis JJ Mobini N Yunis EJ et al. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid Proc Natl Acad Sci USA 1994 91 7747 51
15. Setterfield J Theron J Vaughan RW et al. Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production Br J Dermatol 2001 145 406 14
16. Zillikens D Giudice GJ BP180/type XVII collagen: its role in acquired and inherited disorders or the dermal-epidermal junction Arch Dermatol Res 1999 291 187 94
17. Zillikens D Mascaro JM Rose PA et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid J Invest Dermatol 1997 109 679 83
18. Giudice GJ Wilske KC Anhalt GJ et al. Development of an ELISA to detect anti- BP180 autoantibodies in bullous pemphigoid and herpes gestationis J Invest Dermatol 1994 102 878 81
19. Skaria M Salomon D Jaunin F et al. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180 Dermatology 1999 199 253 5
20. Liu Z Diaz LA Troy JL et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180 J Clin Invest 1993 92 2480 8
21. Sitaru C Schmidt E Petermann S et al. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin J Invest Dermatol 2002 118 664 71
22. Colon JE Bhol KC Razzaque MS Ahmed AR In vitro organ culture model for mucous membrane pemphigoid Clin Immunol 2001 98 229 34
23. Lee JB Liu Y Hashimoto T Cicatricial pemphigoid sera specifically react with the most C-terminal portion of BP180 J Dermatol Sci 2003 32 59 64
24. Nonaka S Ishiko A Masunaga T et al. The extracellular domain of BPAG2 has a loop structure in the carboxy terminal flexible tail in vivo J Invest Dermatol 2000 115 889 92
25. Black MM Bhogal BS Diagnosis, diagnostic and research techniques. In: Management of Blistering Diseases Briggaman RA Wojnarowska F, eds) New York Raven Press 1990 15 34
26. Ohata Y Hashimoto T Nishikawa T Comparative study of autoantigens for various bullous skin diseases by immunoblotting using different dermo-epidermal separation techniques Clin Exp Dermatol 1995 20 454 8
27. Oyama N Bhogal BS Carrington P et al. Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting Br J Dermatol 2003 148 939 44
28. Schumann H Baetge J Tasanen K et al. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases Am J Pathol 2000 156 685 95
29. Marinkovich MP Taylor TB Keene DR et al. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells J Invest Dermatol 1996 106 734 8
30. Zone JJ Taylor TB Meyer LJ Petersen MJ The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2 J Invest Dermatol 1998 110 207 10
31. Shimizu H Takizawa Y Pulkkinen L et al. The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1 J Invest Dermatol 1998 111 887 92
32. Marinkovich MP Tran HH Rao SK et al. LAD-1 is absent in a subset of junctional epidermolysis bullosa patients J Invest Dermatol 1997 109 356 9
33. Saunders DN Buttigieg KM Gould A et al. Immunological detection of conformational neoepitopes associated with the serpin activity of plasminogen activator inhibitor type-2 J Biol Chem 1998 273 10965 71
34. Meyer LJ Taylor TB Kadunce DP et al. Bullous pemphigoid antigens: extraction and degradation of antigens during epidermal preparation J Invest Dermatol 1991 96 991 3
35. Hirako Y Nishizawa Y Sitaru C et al. The 97 kDa (LABD97) and 120 kDa (LAD-1) fragments of bullous pemphigoid antigen 180/type XVII collagen have different N-termini J Invest Dermatol 2003 121 1554 6
36. 4 important for hemidesmosome assembly J Cell Sci 2003 116 387 99
37. Hall RP Murray JC McCord MM et al. Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid J Invest Dermatol 1993 101 9 14
38. Chan LS Vanderlugt CJ Hashimoto T et al. Epitope spreading: lessons from autoimmune skin diseases J Invest Dermatol 1998 110 103 9
39. Alarcon-Segovia D Ruiz-Arguelles A Llorente L Broken dogma: penetration of autoantibodies into living cells Immunol Today 1996 17 163 4
40. Meek B Speijer D de Jong PT et al. The ocular humoral immune response in health and disease Prog Retin Eye Res 2003 22 391 415
41. White KD Capra JD Targeting mucosal sites by polymeric immunoglobulin receptor-directed peptides J Exp Med 2002 196 551 5
42. Sarret Y Hall R Cobo LM et al. Salt-split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies J Am Acad Dermatol 1991 24 952 8
43. Frank MM The complement system in host defense and inflammation Rev Infect Dis 1979 1 483 501
44. Russell MW Mansa B Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA Scand J Immunol 1989 19 175 83
45. Vodegel RM de Jong MC Pas HH Jonkman MF IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature J Am Acad Dermatol 2002 47 919 25